FdaApplication
NDA 217514
Identifiers
- fda_app_no: NDA217514
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2023-03-16 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TAFINLAR | DABRAFENIB MESYLATE | 10MG | TABLET;ORAL SUSPENSION |
| TAFINLAR | DABRAFENIB MESYLATE | 75MG | CAPSULE;ORAL |
| TAFINLAR | DABRAFENIB MESYLATE | EQ 10MG BASE | TABLET, FOR SUSPENSION;ORAL |
3 products